NCT07057570

Brief Summary

Novel Difficult Thyroidectomy Score to predict Difficult thyroidectomies pre operatively .

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
136

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 14, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 14, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 30, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 10, 2025

Completed
Last Updated

July 10, 2025

Status Verified

June 1, 2025

Enrollment Period

1.5 years

First QC Date

June 30, 2025

Last Update Submit

July 9, 2025

Conditions

Keywords

Difficult thyroidectomiesTDS score

Outcome Measures

Primary Outcomes (1)

  • Difficult thyroidectomy

    Any thyroidectomy with score cut off value \> 10

    Time required for surgery

Study Arms (1)

All patients undergoing thyroidectomy

No intervention , just observation

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Pakistani Local population (Asian)

You may qualify if:

  • All MNG undergoing thyroidectomy Euthyroid /toxic controlled cases Age 18-60yrs Both genders

You may not qualify if:

  • carcinomas Co morbs Toxicity signs Pregnancy /lactation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kemu

Lahore, Punjab Province, 5900, Pakistan

Location

MeSH Terms

Conditions

Thyroid Diseases

Condition Hierarchy (Ancestors)

Endocrine System Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 30, 2025

First Posted

July 10, 2025

Study Start

July 1, 2023

Primary Completion

January 14, 2025

Study Completion

January 14, 2025

Last Updated

July 10, 2025

Record last verified: 2025-06

Locations